New SEC Document(s) for Vertex Pharmaceuticals Incorporated

SEC Filing Alert Vertex Pharmaceuticals Incorporated has filed the following document(s) with the United States Securities and Exchange Commission. Feb 29, 2012 Form 4 / Boger, Joshua S HTML PDF View all SEC Filings

You are subscribed to Vertex Pharmaceuticals Incorporated Investor Relations' e-mail alerts as clotito+biotechdash@gmail.com. To update your e-mail and alert preferences, please click here. To unsubscribe, please click here. Vertex Pharmaceuticals Incorporated 130 Waverly Street , Cambridge, MA 02139-4242 Service provided by Shareholder.com